These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16543910)

  • 1. How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients.
    Konrady AO; Kasherininov YR; Shavarov AA; Shavarova EK; Vachrameeva NV; Krutikov AN; Smirnova EV; Shlyakhto EV
    J Hum Hypertens; 2006 Jun; 20(6):398-406. PubMed ID: 16543910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
    Panfilov V; Morris AD; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
    Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
    Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
    Anichkov DA; Shostak NA; Schastnaya OV
    Curr Med Res Opin; 2005 Jan; 21(1):113-9. PubMed ID: 15881482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension.
    Nowak Ł; Adamczak M; Wiecek A
    Am J Hypertens; 2005 Nov; 18(11):1470-5. PubMed ID: 16280284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.
    De Luca N; Izzo R; Fontana D; Iovino G; Argenziano L; Vecchione C; Trimarco B
    J Hypertens; 2000 Oct; 18(10):1515-22. PubMed ID: 11057441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of rilmenidine (hyperium) on lipid balance in hyperlipidemic hypertensive patients. Randomized, controlled, double-blind 8-week study vs. captopril in parallel groups].
    Scemama M; Février B; Beucler I; Dairou F
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):595-601. PubMed ID: 9033699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
    Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.
    Mörtsell D; Malmqvist K; Held C; Kahan T
    J Intern Med; 2007 May; 261(5):472-9. PubMed ID: 17444886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of rilmenidine on neurogenic hypertension in BPH/2J genetically hypertensive mice.
    Jackson KL; Palma-Rigo K; Nguyen-Huu TP; Davern PJ; Head GA
    J Hypertens; 2014 Mar; 32(3):575-86. PubMed ID: 24275840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy.
    Avanza AC; Mansur AP; Ramires JA
    J Hum Hypertens; 2009 Apr; 23(4):259-66. PubMed ID: 18946484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion.
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    J Hypertens; 2004 Aug; 22(8):1529-34. PubMed ID: 15257176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.
    Bönner G; Schmieder R; Chrosch R; Weidinger G
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):21-6. PubMed ID: 9140673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rilmenidine: a clinical overview.
    Reid JL
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):106S-111S. PubMed ID: 10921529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.